Lexicon Pharmaceuticals Inc. convened an in-person Roundtable in Washington, D.C. in October 2025, bringing together diverse stakeholders to address the unmet needs of people living with chronic pain. The event focused on accelerating innovation and expanding access to novel non-opioid therapies, aiming to shape legislative priorities and improve patient outcomes. The findings from this Roundtable are summarized in a recently published White Paper titled "Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain."

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9622758-en) on January 09, 2026, and is solely responsible for the information contained therein.